| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |